国际麻醉学与复苏杂志   2023, Issue (7): 0-0
    
线粒体在脓毒症相关性脑病发病机制与治疗中的研究进展
范璐璐, 孙美艳, 董建欣, 陈轲, 赵晓勇1()
1.潍坊医学院麻醉学院 山东省医药卫生临床麻醉重点实验室
Mitochondria in the pathogenesis and treatment of sepsis associated encephalopathy
 全文:
摘要:

脓毒症相关性脑病(sepsis‑associated encephalopathy, SAE)是脓毒症患者的严重弥散性脑功能障碍。线粒体作为能量代谢的重要场所,其结构改变和功能障碍与SAE的发生密切相关。文章主要探讨了线粒体在SAE中的可能发病机制,并围绕维持线粒体动力学稳态、改善线粒体能量代谢、抑制线粒体氧化应激、减轻线粒体损伤介导的细胞凋亡、调节线粒体自噬进行综述,旨在为SAE的治疗提供新思路。此外,重型及危重型新型冠状病毒感染(COVID‑19)会并发脓毒症,线粒体可能会成为治疗COVID‑19并发SAE的新靶点。

关键词: 脓毒症; 脓毒症相关性脑病; 线粒体损伤; 新型冠状病毒感染
Abstract:

Sepsis‑associated encephalopathy (SAE) is a severe diffuse brain dysfunction in patients with sepsis. The mitochondria are an important site of energy metabolism, and mitochondrial structural changes and dysfunction are closely related to the occurrence of SAE. This paper mainly discusses the possible pathogenesis of the mitochondria in SAE, and summarizes the maintenance of mitochondrial dynamic homeostasis, improvement of mitochondrial energy metabolism, inhibition of mitochondrial oxidative stress, reduction of mitochondrial damage‑mediated apoptosis, and regulation of mitochondrial autophagy, in order to provide new ideas for the treatment of SAE. In addition, severe and critical Coronavirus Disease 2019 (COVID‑19) can be complicated by sepsis. The mitochondria may serve as a new target for the treatment of COVID‑19 complicated by SAE.

Key words: Sepsis; Sepsis‑associated encephalopathy; Mitochondrial damage; Coronavirus disease 2019